New Models for Therapeutic Innovation from Japan
نویسندگان
چکیده
منابع مشابه
New Models for Therapeutic Innovation from Japan
Medical innovation has an extraordinary attrition rate. More than the same time reported disastrous results for AMD therapy using autol95% of drug candidates fail to receive final approval for patient care, and to reachmarket the average drug requires a dozen years of research and development at a cost in the billions of dollars (Giri and Bader, 2015). Medical companies are responding by seekin...
متن کاملa new approach to credibility premium for zero-inflated poisson models for panel data
هدف اصلی از این تحقیق به دست آوردن و مقایسه حق بیمه باورمندی در مدل های شمارشی گزارش نشده برای داده های طولی می باشد. در این تحقیق حق بیمه های پبش گویی بر اساس توابع ضرر مربع خطا و نمایی محاسبه شده و با هم مقایسه می شود. تمایل به گرفتن پاداش و جایزه یکی از دلایل مهم برای گزارش ندادن تصادفات می باشد و افراد برای استفاده از تخفیف اغلب از گزارش تصادفات با هزینه پائین خودداری می کنند، در این تحقیق ...
15 صفحه اولNew business models for antibiotic innovation
The increase in antibiotic resistance and the dearth of novel antibiotics have become a growing concern among policy-makers. A combination of financial, scientific, and regulatory challenges poses barriers to antibiotic innovation. However, each of these three challenges provides an opportunity to develop pathways for new business models to bring novel antibiotics to market. Pull-incentives tha...
متن کاملCriteria for Ranking Therapeutic Innovation
Introduction Innovation in drug therapy is a source of continuing debate for all those who, for various reasons, are concerned with drugs: manufacturers, regulatory agencies, academia, health care professionals and patients. The term “innovative” often tends to be used to define a new drug proposed for entry onto the market, while it is instead necessary to find a more precise definition of thi...
متن کاملHybrid Innovation in Meiji Japan
Japan’s hybrid system during the Meiji era of technological modernization provides a useful laboratory for examining whether complementary mechanisms to patents induce innovation. Patents were introduced in 1885 and by 1911 1.2 million mostly non-pecuniary prizes were awarded at 8,503 competitions. Prizes increased patent outcomes by 35 percent, a conservative causal estimate based on the timin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: EBioMedicine
سال: 2017
ISSN: 2352-3964
DOI: 10.1016/j.ebiom.2017.03.042